论文部分内容阅读
英国精神病学专家，Ｍｏｎｔｇｏｍｅｒｙ教授认为Ｐｈａｒｍａｃｉａ＆Ｕｐｊｏｈｎ公司的选择性去甲肾上腺素重摄取抑制剂（ＳＮＲＩ）瑞波西汀（ｒｅｂｏｘｅ－ｔｉｎｅ）用于抑郁症的一线治疗较礼莱公司的选择性５－羟色胺重摄取抑制剂（ＳＳＲＩ）氟西汀要好，瑞波西汀的
British Psychiatrist, Professor Montgomery, sees Pharmacia & Upjohn’s selective norepinephrine reuptake inhibitor (SNRI) reboxe-tine as first-line treatment for depression Lilly’s Selective Serotonin Inhalation inhibitor (SSRI) fluoxetine is better, reboxetine